Ntt Biopharma 奈力生醫

Nano Targeting and Therapy (NTT) Biopharma Inc. is a cutting-edge biotechnology company pioneering the use of mesoporous silica nanoparticles (MSNs) for the precise and efficient delivery of therapeutic molecules. The company’s innovative nanoparticle platform is designed to overcome biological barriers, enhancing the effectiveness of small molecules, peptides, nucleic acids, including antisense oligonucleotides and plasmids for transient gene therapy and other therapeutic approaches. Our vision is to tackle critical challenges and deliver improved solutions in drug delivery to address unmet medical needs in the fields of brain diseases, ocular and retinal diseases, oncology, and gene therapy. We are committed to create a new generation of effective nanomedicines that optimize therapies across a broad range of diseases. We develop our own new drugs and provide services to external companies including novel chemical entities and approved drugs through the 505B2 pathway. We welcomes strategic and business partners for the co-development of technologies and nano-pharmaceutical products Contact Us Cheng-Hsun Wu Tel:+886-2-23657579 Email: cheng-hsun.wu@nttbiopharma.com